These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 808056)
1. [Characteristics of the immunogenic properties of cholerogen-anatoxin according to gel precipitation reactions and quantity of reducing sugars]. Dzhaparidze MN; Martens LA; Egorova VD; Karaeva LT; Derteva II Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):48-51. PubMed ID: 808056 [TBL] [Abstract][Full Text] [Related]
2. [Immunochemical and biochemical characteristics of a preventive preparation against cholera, cholerogen-toxoid]. Dzhaparidze MN; Sumarokov AA; Martens LA; Egorova VD; Karaeva LT Zh Mikrobiol Epidemiol Immunobiol; 1976 May; (5):32-7. PubMed ID: 941601 [TBL] [Abstract][Full Text] [Related]
3. [Reactogenicity and immunologic effectiveness of cholerogen-anatoxin. Feasibility of revaccination with cholerogen-anatoxin, determination of optimal doses and times for administration]. Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):85-91. PubMed ID: 1024451 [TBL] [Abstract][Full Text] [Related]
4. [Standardization of chemical cholerogen-toxoid cholera vaccine according to the content of somatic O-antigen]. Sumarokov AA; Dzhaperidze MN; Ivanov NR; Karaeva LT; Popov AA Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):99-106. PubMed ID: 405829 [TBL] [Abstract][Full Text] [Related]
8. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity. Svennerholm AM Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500 [TBL] [Abstract][Full Text] [Related]
9. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen. Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117 [TBL] [Abstract][Full Text] [Related]
15. [Immunochemical analysis of the cytoplasmic fraction of a cholera-like vibrion]. Vvedenskaia OI; Stanislavskiĭ ES; Ermol'eva ZV Zh Mikrobiol Epidemiol Immunobiol; 1975 Jan; (1):8-13. PubMed ID: 804781 [TBL] [Abstract][Full Text] [Related]
16. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid. Sinha VB; Bhaskaran K Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387 [TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar]. Toporkov AV; Zadnova SP; Smirnova NI Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):53-7. PubMed ID: 15773401 [TBL] [Abstract][Full Text] [Related]
18. [The population composition of cultures of Vibrio cholerae strain 569 B Pakistan in relation to the manufacture of a cholera vaccine (choleragen-anatoxin+O-antigen)]. Lobanov VV; Nechetskaia RM; Adamova GV Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):73-6. PubMed ID: 2461623 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of reactions and serological response to cholera vaccines in a controlled field trial conducted in the USSR. Burgasov PN; Sumarokov AA; Lelikov VL; Marcuk LM; Fedenev VG; Dzaparidze MN; Karaeva LT; Derteva II Bull World Health Organ; 1976; 54(2):163-70. PubMed ID: 798636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]